You are here: Industry Insights > COVID-19 Patients

News List

Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients prnasia
September 28, 2021
Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics...
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients prnasia
March 25, 2020
Ascletis Pharma Inc. (HKEX code: 1672) announces today the first clinical study using Ganovo®(danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv.
COVID-19 patients must be treated with differentiated therapies chinadaily
March 25, 2020
Chinese medical experts have emphasized using different therapies to treat patients with different symptoms of the novel coronavirus disease (COVID-19).
Vice-premier stresses scientific, precise treatment of COVID-19 patients chinadaily
March 16, 2020
Vice-Premier Sun Chunlan has reiterated the need to make all-out efforts to save COVID-19 patients in Central China's Hubei province, stressing scientific and precise treatment.